Respiratory diseases can be caused by more than 300 microorganisms: viruses, bacteria, fungi and some other pathogens.
It is worth remembering that the upper respiratory tract is closely connected with the paranasal sinuses and the middle ear. This creates conditions that might lead to pathological processes. To prevent a development of the disease to chronic condition, and avoid any unwanted complications, a timely treatment is required.
Miramistin® is often prescribed by otorhinolaryngologist in case of acute and chronic diseases of ENT organs. In adults it is used in complex therapy of the larynx and pharynx, pharyngitis, tonsillitis, sinusitis and otitis. And in children 3 to 14 years old it is used in acute pharyngitis and exacerbation of chronic tonsillitis.
Miramistin® has a combined effect on pathogens and mucous membranes of the respiratory tract. The key benefit of medicine is a wide antimicrobial activity against a large number of bacteria, including strains resistant to antibiotics, viruses, fungi etc. Moreover, Miramistin® reduces inflammation of mucous membranes of the respiratory tract, improves their healing processes and stimulates local protective reactions.
The properties of Miramistin® improve the overall effectiveness of complex therapy that has been proven in studies. One of them showed that the use of Miramistin® in treatment of acute laryngitis shortens treatment period, while in case of exacerbation of chronic disease it accelerates the achievement of remission.